The Week In Cannabis: Canopy’s Earnings, JPMorgan’s Restrictions, A Slew Of Earnings, Big Policy Moves
Below is a recap of the main news related to the cannabis industry and markets for the week of November 1st, 2021.
Contents
Analyst Lowers Price Targets On These Leading Stocks; $TLRY Enters Spirits Market – Cannabis Daily, November 4, 2021
Start The Day With The Best Daily Pre-Market Overview Of The Cannabis Space
Cantor Fitzgerald releases notes on several major cannabis companies:
Green Thumb Industries(OTCQX: GTBIF)
What’s In The Cards For Cannabis MSOs In Q3? Analyst’s Thoughts Ahead Of Earnings Season
With earnings season underway, investors should be closely watching top cannabis stocks over the coming weeks.
Some of the largest cannabis MSOs in the U.S. are about to publish their quarterly financial reports and Cantor Fitzgerald’s Pablo Zuanic provided third-quarter estimates for the ten companies within the group.
Cantor Fitzgerald Maintains Overweight on Columbia Care, Lowers Price Target to $5.2
Cantor Fitzgerald analyst Pablo Zuanic maintains Columbia Care (OTC:CCHWF) with a Overweight and lowers the price target from $5.5 to $5.2.
New York Cannabis Control Board Pondering A Ban Of Delta-8 THC
Months after the legalization of adult-use cannabis, New York might decide to join the growing number of states prohibiting the sale of delta-8 THC.
Columbia Care Strengthens Presence In Colorado: Closes $42M Acquisition Of Medicine Man
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE:3LP) announced Monday it has wrapped up the previously announced acquisition of the C
EXCLUSIVE: What Makes Columbia Care Such A Successful Cannabis Company?
Jesse Channon, chief growth officer at Columbia Care (OTC: CCHWF), one of the oldest cultivators in the cannabis space, was a guest at a special broadcast of the Benzinga Cannabis Hour, strea
Goodness Growth’s Whole Flower Products Now Available In Several New York Cannabis Dispensaries
Science-focused cannabis company and IP developer Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF) announced Friday that its Vireo Health of New York subsidiary is launching whole flower cannabis products at three of its four New York dispensaries.
Mike Tyson On Cannabis: ‘I Should Have Smoked My Whole Career’
Speaking with Yahoo Finance about the debut of the Tyson 2.0 cannabis line, in partnership with Columbi
Curaleaf, Columbia Care, PharmaCann Begin Whole Flower Cannabis Sales In New York
New York's long-awaited adult-use cannabis program is live, almost. As it evolves, big names in the space are eager to take their place although the ten operators already running medical cannabis businesses in the Empire State have the home team advantage.